Data for ST003417   

(Analysis AN005616): Average values per metabolite and experimental factor (Units:Counts per second (cps))

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10F11F12F13
O-Acetylcarnitine 85
214428326.87 198541113.63 215984744.93 218895003.67 218371745.97 185943593.00 247802398.73 219907073.03 205253799.93 182932296.63 325319146.80 291853270.67 195582763.00
O-Acyl(17:1)carnitine 85
100240.04 122215.50 35687.70 60010.26 119478.13 119958.49 76759.61 61600.78 68976.20 95384.73 68257.82 53775.65 100257.49
O-Butyrylcarnitine 85
29754633.14 33017140.59 8977332.33 7580012.19 27367871.65 25911282.47 5369945.86 3727508.48 20846886.36 21567284.70 3404880.38 2553016.23 30112846.04
O-Caproylcarnitine 85
3497459.11 3674529.77 2726537.62 2981462.56 3384955.37 3280098.66 3823896.62 3541711.35 3567861.83 3482726.90 4233216.96 3989211.31 3805756.50
O-Caprylcarnitine 85
331147.13 473504.42 318484.59 155793.68 404909.46 374075.73 273829.75 295850.71 324418.52 299583.86 226053.87 233449.86 364752.49
O-Caprylylcarnitine 85
1144730.88 1243710.61 1032326.61 1286971.45 1300259.48 974030.83 1078961.29 1068445.65 1239242.46 987913.50 1204628.92 949924.52 1441943.32
O-Enanthylcarnitine 85
2064680.25 2545988.13 1526393.56 2671772.07 3270144.00 1535642.79 2624204.31 1624736.32 2233785.19 1405432.42 3191976.83 3001185.15 2551657.04
O-Formyl-L-carnitine 85
48421.54 62255.89 33333.18 20352.64 65798.86 59383.33 39053.33 75613.68 91845.38 39650.57 61023.05 62509.19 66831.67
O-Lauroleoylcarnitine 85
227061.98 174803.83 214896.05 215905.60 145111.81 256643.32 193012.95 227828.49 206251.68 190698.57 218270.73 135604.16 197149.70
O-Lauroylcarnitine 85
332635.45 356645.83 148469.85 78437.66 297707.85 285818.77 129900.97 117836.80 232636.81 253077.52 122537.78 80831.21 329774.68
O-Malonylcarnitine 85
215631.62 189850.63 492178.05 354353.71 209377.84 191218.14 1050091.12 753675.38 214739.70 188654.84 2831079.02 1408867.11 171314.39
O-Margaroylcarnitine 85
128888.82 195334.19 79518.30 96506.44 178950.45 178004.63 94447.44 79876.31 108988.42 156955.22 72271.68 64497.18 160298.15
O-Myristoleoylcarnitine 85
415788.61 435908.23 155047.24 172724.03 381734.21 430095.44 134169.92 171456.55 384197.75 379736.38 91760.27 153016.69 470439.73
O-Myristoylcarnitine 85
4543583.74 5806834.29 682542.04 622078.93 3982070.28 4429870.41 365603.22 376098.15 2938674.87 2929968.36 213610.87 251785.49 5206742.77
O-Oleoylcarnitine 85
1461940.68 1869371.89 504583.61 680632.15 1489439.81 1571338.08 407756.53 368305.57 1204685.79 1387905.96 212621.92 324697.98 1651605.31
O-Palmitoleoylcarnitine 85
1810235.13 2082762.24 454792.63 403765.12 1580522.22 1709298.88 296460.37 270873.91 1346298.64 1316255.00 195331.21 251000.11 1923921.22
O-Palmitoylcarnitine 85
8613372.27 10188430.40 1587689.59 1675138.52 7309565.81 7860536.48 849711.78 891752.31 5844381.67 6270200.10 549007.76 682098.24 9054181.72
O-Pelargonylcarnitine 85
130620.17 159295.17 116202.55 153653.12 139290.79 108722.74 148900.51 154392.21 114685.52 160368.46 86797.96 104446.60 157588.45
O-Pentadecyloylcarnitine 85
311236.71 324551.72 104811.06 131096.47 264416.57 292157.02 103566.20 90285.13 265434.86 205484.76 109645.08 78200.65 279546.29
O-Propionylcarnitine 85
15822060.69 18878860.41 14930246.80 14796190.59 16972438.82 16107914.48 15997747.24 16675317.08 14574646.77 16795902.79 16949180.64 10948608.41 18162493.03
O-Stearoylcarnitine 85
742590.64 702103.24 264510.10 339387.83 623165.31 626527.95 198552.28 257062.42 529934.89 539130.96 157492.90 172581.63 622670.98
O-Tridecyloylcarnitine 85
88469.48 83159.42 93629.65 88006.52 128808.89 71333.68 72642.97 84657.55 87575.60 84350.20 102856.11 50230.63 105205.31
O-Undecyloylcarnitine 85
162376.69 235698.74 217168.65 202233.09 173034.61 182073.85 205831.11 145259.00 197333.97 194543.73 143152.75 163636.31 195878.69
O-Valerylcarnitine 85
21946848.62 25978512.75 18962729.05 22791268.64 24237058.31 19683641.10 21597306.70 17127404.60 26315970.09 17962840.02 19769142.10 21612988.47 24609016.80

Factors:

F1Sample source:BT-474 Breast cancer cells | Drug Treatment:1 nM TVB-2640
F2Sample source:BT-474 Breast cancer cells | Drug Treatment:1 nM TVB-3166
F3Sample source:BT-474 Breast cancer cells | Drug Treatment:200 nM TVB-2640
F4Sample source:BT-474 Breast cancer cells | Drug Treatment:200 nM TVB-3166
F5Sample source:BT-474 Breast cancer cells | Drug Treatment:20 nM TVB-2640
F6Sample source:BT-474 Breast cancer cells | Drug Treatment:20 nM TVB-3166
F7Sample source:BT-474 Breast cancer cells | Drug Treatment:500 nM TVB-2640
F8Sample source:BT-474 Breast cancer cells | Drug Treatment:500 nM TVB-3166
F9Sample source:BT-474 Breast cancer cells | Drug Treatment:50 nM TVB-2640
F10Sample source:BT-474 Breast cancer cells | Drug Treatment:50 nM TVB-3166
F11Sample source:BT-474 Breast cancer cells | Drug Treatment:5 uM TVB-2640
F12Sample source:BT-474 Breast cancer cells | Drug Treatment:5 uM TVB-3166
F13Sample source:BT-474 Breast cancer cells | Drug Treatment:Control
  logo